Cell-Free DNA for Minimal Residual Disease Monitoring in Multiple Myeloma Patients

被引：0

作者：

Kubiczkova-Besse, Lenka ^{[1
,2
]}

Drandi, Daniela ^{[3
]}

Sedlarikova, Lenka ^{[1
,4
]}

Oliva, Stefania ^{[3
]}

Gambella, Manuela ^{[3
]}

Omede, Paola ^{[5
]}

Adam, Zdenek ^{[6
]}

Pour, Ludek ^{[4
]}

Sevcikova, Sabina ^{[1
,4
]}

Boccadoro, Mario ^{[7
]}

Palumbo, Antonio ^{[3
]}

Hajek, Roman ^{[1
,6
,8
,9
]}

机构：

[1] Masaryk Univ, Fac Med, Dept Pathol Physiol, Babak Myeloma Grp, Brno, Czech Republic

[2] Univ Hosp Brno, Dept Clin Hematol, Brno, Czech Republic

[3] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Div Hematol, Turin, Italy

[4] Univ Hosp Brno, Brno, Czech Republic

[5] Univ Turin, AOU Citta Salute & Sci, Turin, Italy

[6] Univ Hosp, Brno, Czech Republic

[7] Univ Turin, Div Hematol, Myeloma Unit, Turin, Italy

[8] Univ Hosp Ostrava, Ostrava, Czech Republic

[9] Univ Ostrava, Fac Med, CZ-70103 Ostrava, Czech Republic

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] Minimal Residual Disease in Multiple Myeloma Patients: Influence on Indicators of Progression Free Survival
Garifullin, Andrei
Voloshin, Sergei
Martynkevich, Irina
Kuvshinov, Alexey
Kleina, Elizaveta
Shuvaev, Vasily
Abdulkadyrov, Kudrat
BLOOD, 2016, 128 (22)
[22] Minimal Residual Disease in Multiple Myeloma
Munshi, Nikhil C.
Anderson, Kenneth C.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : 2523 - 2526
[23] Minimal residual disease for multiple myeloma
Avet-Loiseau, Herve
Corre, Jill
HEMATOLOGIE, 2019, 25 : 36 - 39
[24] Minimal residual disease in multiple myeloma
Moukalled, Nour
Malard, Florent
Bazarbachi, Ali
Mohty, Mohamad
PRESSE MEDICALE, 2025, 54 (01):
[25] Tumour markers for monitoring minimal residual disease in multiple myeloma.
Rothwell, DG
Kalakonda, N
Norton, JD
Hawkins, RE
Chopra, R
BLOOD, 2000, 96 (11) : 151A - 151A
[26] Circulating Tumour DNA for Detecting Minimal Residual Disease in Multiple Myeloma
Pugh, Trevor J.
SEMINARS IN HEMATOLOGY, 2018, 55 (01) : 38 - 40
[27] The role of minimal residual disease evaluation for patients with multiple myeloma
Eun, Yoon Sang
Kim, Hyun-Young
Cho, Duck
Kim, Seok Jin
Kim, Kihyun
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S80 - S80
[28] MINIMAL RESIDUAL DISEASE IN THE CLINICAL PRACTICE OF MULTIPLE MYELOMA PATIENTS
Cedena, M. T.
Puig, N.
Paiva, B.
Perez, A.
De Arriba, F.
Cuellar, C.
Blanchard, M. J.
Martinez-Chamorro, C.
Casanova, M.
Sirvent, M.
Rodriguez-Otero, P.
Martinez-Lopez, J.
Mateos, M., V
San Miguel, J. F.
Lahuerta, J. J.
HAEMATOLOGICA, 2019, 104 : 15 - 15
[29] Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications
Charalampous, Charalampos
Kourelis, Taxiarchis
FRONTIERS IN ONCOLOGY, 2022, 11
[30] CLINICAL MONITORING OF MEASURABLE RESIDUAL DISEASE BY CELL-FREE DNA IN PEDIATRIC BRAIN TUMORS
Crotty, Erin
Cole, Bonnie
Paulson, Vera
Lockwood, Christina
Leary, Sarah
NEURO-ONCOLOGY, 2023, 25

← 1 2 3 4 5 →